Evidence map›Paper›PMID 35765299›Full record

ArticleERJ open research2022

A novel model to predict severe COVID-19 and mortality using an artificial intelligence algorithm to interpret chest radiographs and clinical variables.

Nicolás Munera, Esteban Garcia-Gallo, Álvaro Gonzalez, José Zea, Yuli V Fuentes, Cristian Serrano, Alejandra Ruiz-Cuartas, Alejandro Rodriguez, Luis F Reyes

Abstract read
In one paragraph

Article in ERJ open research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nicolás MuneraArkangel AI, Bogotá, Colombia.
Esteban Garcia-GalloDepartment of Infectious Diseases, Universidad de la Sabana, Chía, Colombia.
Álvaro GonzalezArkangel AI, Bogotá, Colombia.
José ZeaArkangel AI, Bogotá, Colombia.
Yuli V FuentesDepartment of Infectious Diseases, Universidad de la Sabana, Chía, Colombia.
Cristian SerranoDepartment of Infectious Diseases, Universidad de la Sabana, Chía, Colombia.ORCID https://orcid.org/0000-0001-8344-0535
Alejandra Ruiz-CuartasDepartment of Infectious Diseases, Universidad de la Sabana, Chía, Colombia.
Alejandro RodriguezCentro de Investigación Biomédica en Red de Enfermedades Respiratorias, Hospital Universitari Joan XXIII and Rovira & Virgili University, Tarragona, Spain.
Luis F ReyesDepartment of Infectious Diseases, Universidad de la Sabana, Chía, Colombia.ORCID https://orcid.org/0000-0003-1172-6539

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Patients with coronavirus disease 2019 (COVID-19) could develop severe disease requiring admission to the intensive care unit (ICU). This article presents a novel method that predicts whether a patient will need admission to the ICU and assesses the risk of in-hospital mortality by training a deep-learning model that combines a set of clinical variables and features in chest radiographs. Methods: This was a prospective diagnostic test study. Patients with confirmed severe acute respiratory syndrome coronavirus 2 infection between March 2020 and January 2021 were included. This study was designed to build predictive models obtained by training convolutional neural networks for chest radiograph images using an artificial intelligence (AI) tool and a random forest analysis to identify critical clinical variables. Then, both architectures were connected and fine-tuned to provide combined models. Results: 2552 patients were included in the clinical cohort. The variables independently associated with ICU admission were age, fraction of inspired oxygen ( Conclusions: This automated chest radiograph interpretation algorithm, along with clinical variables, is a reliable alternative to identify patients at risk of developing severe COVID-19 who might require admission to the ICU.

Identifiers

PMID35765299
PMCPMC9059131

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.